Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. [electronic resource]
Producer: 20030204Description: 251-5 p. digitalISSN:- 0732-183X
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Astrocytoma -- drug therapy
- Brain Neoplasms -- drug therapy
- Chromosome Aberrations
- Chromosome Deletion
- Chromosomes, Human, Pair 1 -- genetics
- Chromosomes, Human, Pair 19 -- genetics
- Female
- Humans
- In Situ Hybridization, Fluorescence
- Lomustine -- therapeutic use
- Male
- Middle Aged
- Oligodendroglioma -- drug therapy
- Procarbazine -- therapeutic use
- Prognosis
- Radiotherapy, Adjuvant
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.